A LinkedIn post from Alchemy highlights that the Injective blockchain is now accessible via Alchemy’s infrastructure platform. The post emphasizes that Injective’s protocol includes a native order book, aiming to let developers focus on applications rather than building trading “plumbing” from scratch.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, Injective offers shared liquidity, MEV‑resistant execution, sub‑second finality, and zero gas fees on trades. It also cites more than $76 billion in cumulative trading volume and over $6.5 billion in real‑world asset derivatives volume, including tokenized gold, crude oil, and U.S. equities.
The post notes that Helix runs spot and perpetual markets entirely on Injective’s native order book, while Joinn Finance uses the same infrastructure to provide emerging market users with access to Treasury yields and ETFs. Alchemy is described as supporting core JSON RPC endpoints for Injective mainnet and testnet, with a workflow similar to that used for Ethereum and Solana.
For investors, the content suggests Alchemy is broadening its multi‑chain coverage into higher‑throughput trading and RWA‑focused ecosystems, which could enhance its relevance to institutional‑grade DeFi projects. Deeper integration with active venues like Helix and RWA platforms such as Joinn Finance may help drive additional usage of Alchemy’s infrastructure, potentially strengthening its competitive position among Web3 developer platforms.